| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 32.296 | 118.656 | 99.016 | 141.625 | 246.393 | 359.340 | 323.416 | 340.474 |
| Total Income - EUR | - | - | 32.296 | 118.656 | 99.016 | 141.625 | 246.393 | 364.668 | 323.943 | 340.474 |
| Total Expenses - EUR | - | - | 11.836 | 40.526 | 37.013 | 34.859 | 97.097 | 178.496 | 184.096 | 186.587 |
| Gross Profit/Loss - EUR | - | - | 20.459 | 78.130 | 62.003 | 106.767 | 149.296 | 186.172 | 139.847 | 153.887 |
| Net Profit/Loss - EUR | - | - | 19.491 | 74.570 | 59.033 | 102.715 | 143.954 | 182.598 | 136.995 | 143.671 |
| Employees | - | - | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Enabioart Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 11.978 | 47.528 | 56.868 | 44.002 | 116.988 | 135.212 | 112.659 | 90.543 |
| Current Assets | - | - | 8.979 | 61.033 | 88.042 | 175.183 | 228.399 | 342.529 | 305.575 | 233.165 |
| Inventories | - | - | 1.473 | 2.753 | 2.906 | 13.904 | 8.040 | 21.129 | 4.659 | 58.721 |
| Receivables | - | - | 2.551 | 17.556 | 16.873 | 26.799 | 115.608 | 231.401 | 62.665 | 147.915 |
| Cash | - | - | 4.955 | 40.724 | 68.262 | 134.480 | 104.751 | 89.999 | 238.251 | 26.530 |
| Shareholders Funds | - | - | 19.534 | 93.746 | 130.555 | 202.265 | 324.924 | 182.647 | 157.165 | 143.719 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.783 | 14.815 | 14.372 | 16.948 | 20.511 | 295.393 | 261.102 | 180.061 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Enabioart Srl